CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for AbbVie Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

AbbVie Inc
1 N Waukegan Rd
Phone: (847) 932-7900p:847 932-7900 North Chicago, IL  60064-1802  United States Ticker: ABBVABBV

Business Summary
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201912/31/2018YesYes-YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer Richard A.Gonzalez 65 1/2/2013 1/2/2013
President, Vice Chairman Michael E.Severino 52 12/13/2018 5/15/2014
Vice Chairman, Chief Commercial Officer CarlosAlban 56 12/13/2018 1/2/2013
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ABBVIE INC.
Stemcentrx, Inc. 450 East Jamie Court South San Francisco CA United States
Pharmacyclics, Inc. 995 E ARQUES AVE SUNNYVALE CA United States

Business Names
Business Name
0QCV
ABBV
AbbVie (Gibraltar) Holdings Limited
134 additional Business Names available in full report.

General Information
Number of Employees: 30,000 (As of 12/31/2018)
Outstanding Shares: 1,478,779,037 (As of 9/16/2019)
Shareholders: 48,516
Stock Exchange: NYSE
Federal Tax Id: 320375147
Fax Number: (302) 655-5049


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, September 20, 2019